The analyst performs a test using a drop of blood obtained by fingerstick or venipuncture from the patient to rapidly measure the level of glycosylated hemoglobin, HgbA1c. The analyst uses a device the FDA has approved for home use. This test is an indication of glucose control over a three to four month period and results show as a percent of total hemoglobin
For clinical responsibility, terminology, tips and additional info
start codify free trial.